It’s not surprising that executives who once ran a health-care company called Leprechaun L.L.C. would pick an unusual name for their next venture.
But Blood, Sweat & Capital L.L.C.?
Daniel C. Lyons, one of the four partners in the new private-equity firm, said he wasn’t sure who actually came up with the whimsical name. It was the winner from a contest the partners held among their friends and associates.
Their business plan is more serious: funding new health-care services companies. Rather than backing the next diabetes drug, Blood, Sweat & Capital is looking to capitalize on opportunities that the national debate over health reform will spawn.
Lyons said he expects to back new ideas championed by the nurses, allied health professionals and doctors on the front lines of a health-care system often criticized for its inefficiency and cost.
“They see the pain in the health-care system,” he said.
Blood, Sweat & Capital is a virtual company, with Lyons, based in Wayne, its only tie to the Philadelphia area. He retired recently after 14 years as an executive at Independence Blue Cross.
Most recently, Lyons was president and CEO of Veridign Health Solutions, a for-profit subsidiary in Center City that provides “back-office” services to insurers and health plans offering Medicare Advantage insurance coverage.
Based in New York, David Bach, who is CEO of Blood, Sweat & Capital, founded Leprechaun, also focused on Medicare Advantage plans. The other partners - Patrick Aberle in Fort Worth, Texas, and Michael Duffy in the San Francisco area - worked at Leprechaun, which was bought by XLHealth, of Baltimore, in 2007.
Lyons said the partners will use their own capital, but would not say how much they have committed. They intend to invest in the seed-stage range, from $50,000 to $250,000.
Top Dragon
The team of students behind Stabiliz Orthopaedics won Drexel University’s 10th annual Baiada Incubator Competition earlier this month. The medical-device maker gets rent-free space in the campus business incubator for a year, $12,000 in seed capital, and $35,000 in in-kind support, such as legal advice and brand positioning.
- Philly Skyline
- Delaware Business Blog
- PlanPhilly
- Changing Skyline
- Dangerously Awesome
- Greater Philly chamber
- Consumer Inq
- Freakonomics
- Oddly Enough
- Philly PharmaBio Blog
- Physicians News Digest
- Pharmalot
- BloggingStocks
- 10Q Detective
- PhiLAWdelphia
- Delaware Corp Litigation Blog
- Philadelphia Forward
- Great Expectations
- SEPTA Watch
- PhillyFuture
- Comcast Must Die
- Philly Geeks
- Philadelphia Tech News
- Broadband Reports
- Phila Road Warrior
- February
- January
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008







Mike Armstrong, a business editor and writer for nearly two decades, is the Inquirer's business columnist and PhillyInc blog editor. Contact Mike 